A phase II open-label multicenter study of gefitinib in combination with irradiation followed by chemotherapy in patients with inoperable stage III non-small cell lung cancer | Zendy

AI Assistant Blog Pricing

A phase II open-label multicenter study of gefitinib in combination with irradiation followed by chemotherapy in patients with inoperable stage III non-small cell lung cancer

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.